Dr. Habte A Yimer
Claim this profileTexas Oncology - Tyler
Studies Lymphoma
Studies Multiple Myeloma
20 reported clinical trials
38 drugs studied
Area of expertise
1Lymphoma
Stage I
Stage IV
Stage III
2Multiple Myeloma
Affiliated Hospitals
Clinical Trials Habte A Yimer is currently running
GM T Cell Therapy Long-Term Follow-Up
for Cancer
This is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult participants exposed to Gene-modified (GM) T cell therapy participating in a previous Celgene sponsored or Celgene alliance partner sponsored study. Participants who received at least one GM T cell infusion will be asked to enroll in this LTFU protocol upon either premature discontinuation from, or completion of the prior parent treatment protocol.
Recruiting1 award Phase 2 & 3
Cema-cel
for B-Cell Lymphoma
This is a randomized, open-label study in adult patients who have completed standard first line of therapy for large B-cell lymphoma (LBCL) and achieved a complete response or partial response suitable for observation, but who have minimal residual disease (MRD) as detected by the Foresight CLARITY™ Investigational Use Only (IUO) MRD test, powered by PhasED-Seq™. The purpose of the trial is to assess the efficacy and safety of consolidation with cemacabtagene ansegedleucel (cema-cel), an allogeneic CD19 CAR T product, as compared to standard of care observation. The study is conducted in 2 consecutive parts that will be enrolled continuously. In Part A of the study, participants with MRD are randomized to one of two treatment arms or an observation arm. Treatment includes cema-cel following a lymphodepletion regimen of fludarabine and cyclophosphamide administered with or without the anti-CD52 monoclonal antibody, ALLO-647. Part A will culminate with the selection of the lymphodepletion regimen to advance to Part B. Part B will evaluate the selected lymphodepletion regimen followed by cema-cel as compared with observation.
Recruiting1 award Phase 25 criteria
More about Habte A Yimer
Clinical Trial Related5 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Habte A Yimer has experience with
- Rituximab
- Lenalidomide
- Selinexor
- Tazemetostat
- Dexamethasone
- TAK-981
Breakdown of trials Habte A Yimer has run
Lymphoma
Multiple Myeloma
Plasma Cell Neoplasms
Non-Hodgkin's Lymphoma
- A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)
- Cema-cel for B-Cell Lymphoma
- A Study of TAK-981 Given With Rituximab in Adults With Relapsed or Refractory CD20-Positive Non-Hodgkin Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Habte A Yimer specialize in?
Habte A Yimer focuses on Lymphoma and Multiple Myeloma. In particular, much of their work with Lymphoma has involved Stage I patients, or patients who are Stage IV.
Is Habte A Yimer currently recruiting for clinical trials?
Yes, Habte A Yimer is currently recruiting for 6 clinical trials in Tyler Texas. If you're interested in participating, you should apply.
Are there any treatments that Habte A Yimer has studied deeply?
Yes, Habte A Yimer has studied treatments such as Rituximab, Lenalidomide, Selinexor.
What is the best way to schedule an appointment with Habte A Yimer?
Apply for one of the trials that Habte A Yimer is conducting.
What is the office address of Habte A Yimer?
The office of Habte A Yimer is located at: Texas Oncology - Tyler, Tyler, Texas 75702 United States. This is the address for their practice at the Texas Oncology - Tyler.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.